Abstract
We present the case of a patient with granulomatosis with polyangiitis (GPA) treated with rituximab, who was diagnosed with coronavirus disease 2019 (COVID-19). Following an index hospitalization with apparent resolution of the infection, the patient was readmitted with clinical deterioration. While repeat serial real-time polymerase chain reaction (rt-PCR) from nasopharyngeal swabs were negative, a bronchoalveolar lavage (BAL) sample demonstrated persistent COVID-19 to be the etiologic factor. Administration of convalescent plasma led to remarkable recovery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
